Business Context and Reporting Period
This Form 8-K Current Report is filed by Cohu, Inc. for the reporting period of April 6, 2015. The filing addresses corporate governance changes, specifically the termination of a poison pill rights agreement and the resignation of a director.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on legal and governance events rather than financial performance data.
Material Changes
- Termination of Rights Agreement: On April 6, 2015, the Company entered into Amendment No. 1 to its Amended and Restated Rights Agreement, changing the Final Expiration Date to April 6, 2015, effectively terminating the agreement.
- Elimination of Preferred Stock: Following the termination of the Rights Agreement, the Company filed a Certificate of Elimination with the Delaware Secretary of State. This action eliminated the designation of Series A Preferred Stock, returning those shares to the status of authorized but unissued undesignated preferred stock.
- Director Resignation: Harry L. Casari resigned from the Board of Directors effective April 6, 2015, citing health reasons.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or management commentary regarding future business performance. The primary risk addressed is the modification of security holder rights through the elimination of the poison pill provision and the associated preferred stock designation.
Investor Verification Checklist
- Verify the full text of Amendment No. 1 to the Rights Agreement (Exhibit 4.1) to confirm the terms of termination.
- Confirm the filing of the Certificate of Elimination with the Delaware Secretary of State (Exhibit 3.1).
- Review the press release regarding the resignation of Harry L. Casari (Exhibit 99.2) for any additional context on the Board composition.
- Check subsequent filings to determine if a new director was appointed to fill the vacancy left by Mr. Casari.